购物车
- 全部删除
- 您的购物车当前为空
CYP1B1-IN-4为选择性CYP1B1抑制剂(IC50=0.2 nM),属2,4-二芳基噻唑类化合物。其对细胞的毒性低,且在人类及大鼠肝微粒体中表现出稳定性。
为众多的药物研发团队赋能,
让新药发现更简单!
CYP1B1-IN-4为选择性CYP1B1抑制剂(IC50=0.2 nM),属2,4-二芳基噻唑类化合物。其对细胞的毒性低,且在人类及大鼠肝微粒体中表现出稳定性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 248 | 现货 | |
5 mg | ¥ 578 | 现货 | |
10 mg | ¥ 913 | 现货 | |
25 mg | ¥ 1,830 | 现货 | |
50 mg | ¥ 2,890 | 现货 | |
100 mg | ¥ 4,220 | 现货 | |
500 mg | ¥ 8,890 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 723 | 现货 |
产品描述 | CYP1B1-IN-4, a 2,4-diarylthiazole compound, exhibits selective inhibition of CYP1B1 (IC50=0.2 nM), demonstrating minimal cytotoxicity and high stability in human and rat liver microsomes [1]. |
靶点活性 | CYP1B1:0.2 nM, CYP1A1:3.98 μM |
分子量 | 322.38 |
分子式 | C18H14N2O2S |
CAS No. | 2685779-55-7 |
Smiles | O(C)C1=C(C2=NC(=CS2)C3=CC=C(C#N)C=C3)C=CC(OC)=C1 |
存储 | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 8 mg/mL (24.82 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
评论内容